A Concise Review of Molecular Pathology of Breast Cancer
eBook - PDF

A Concise Review of Molecular Pathology of Breast Cancer

  1. 234 pages
  2. English
  3. PDF
  4. Available on iOS & Android
eBook - PDF

A Concise Review of Molecular Pathology of Breast Cancer

About this book

Cancer is one of the leading causes of death in most countries and its consequences result in huge economic, social and psychological burden. Breast cancer is the most frequently diagnosed cancer type and the leading cause of cancer death among females. In this book, we discussed gene expression and DNA abnormalities including methylation in breast cancer. A recent important topic, roles of miRNAs and their potential use in cancer therapy have been discussed in this cancer type as well. Bioinformatics is very important part of recent human genome developments and data mining and thus this topic has also been added for the readers. It is hoped that this book will contribute to development of novel diagnostic as well as therapeutic approaches, which lead to cure of breast cancer.

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access A Concise Review of Molecular Pathology of Breast Cancer by Mehmet Gunduz in PDF and/or ePUB format, as well as other popular books in Medicine & Rheumatology, Orthopedics & Prosthetics. We have over one million books available in our catalogue for you to explore.

Table of contents

  1. A Concise Review of Molecular Pathology of Breast Cancer
  2. Contents
  3. Preface
  4. Chapter 1 Breast Cancer- It’s All in the DNA
  5. Chapter 2 DNA Methylation
  6. Chapter 3 Genome-Wide Gene Expression Analysis to Identify Epistatic Gene-Pairs Associated with Prognosis of Breast Cancer
  7. Chapter 4 MicroRNA in Breast Cancer — Gene Regulators and Targets for Novel Therapies
  8. Chapter 5 MicroRNAs as Therapeutic Targets in Human Breast Cancer
  9. Chapter 6 Plasminogen Activator System — Diagnostic, Prognostic and Therapeutic Implications in Breast Cancer
  10. Chapter 7 Bioinformatics in Breast Cancer Research
  11. Chapter 8 Relationship of Breast Cancer with Ovarian Cancer
  12. Chapter 9 Enantiomerically Pure Substituted Benzo-Fused Heterocycles — A New Class of Anti-Breast Cancer Agents